Tectonic Therapeutic TECX
NASDAQ TECX
$30.81 +0.89 (+2.96%)
As of: Sep 4, 2026 · 3:15 PM EDT

Tectonic Therapeutic (TECX) EV to EBIT (2018 - 2026)

Analysis

Tectonic Therapeutic (TECX) EV to EBIT (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Tectonic Therapeutic 582.01 Mn 582.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.93
Mar 31, 2026 -12.64
Dec 31, 2025 -6.34
Sep 30, 2025 -1.12
Jun 30, 2025 -3.78
Mar 31, 2025 -1.33
Dec 31, 2024 -17.92
Sep 30, 2024 -14.65
Jun 30, 2024 2.57
Mar 31, 2024 -9.74
Dec 31, 2023 -13.37
Sep 30, 2023 -16.63
Jun 30, 2023 -8.71
Mar 31, 2023 -1.63
Dec 31, 2022 0.48
Sep 30, 2022 1.91
Jun 30, 2022 1.01
Mar 31, 2022 3.53
Dec 31, 2021 0.77
Sep 30, 2021 -1.29